IP Library Granted Patent US 10,722,341
Granted Patent B2
US 10,722,341 · App. 16/009,619 · Granted Jul 28, 2020

Biliary stents and methods

Inventors: Kenneth F. Binmoeller (San Francisco, CA); Sieu T. Duong (Hayward, CA); Hanh H. Duong (Hayward, CA); Thao Nguyen (San Jose, CA)
Assignee: Boston Scientific Scimed, Inc.
A61F2/04A61F2/07A61F2/90A61F2002/041A61F2230/001A61F2230/0069A61F2230/0095A61F2250/0019
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,722,341
App. No.
16/009,619
Granted
Jul 28, 2020
Kind
B2
Abstract

A tissue lumen stent is provided with a body having an elongated tubular configuration and a foreshortened configuration. In the foreshortened configuration, downstream and upstream ends of the body expand radially into downstream and upstream flange structures, leaving a generally cylindrical saddle region therebetween. In some embodiments, the flange structures are non-symmetrical with respect to one another. Systems and methods of using the stents are also disclosed.

Claims (37)

1. A stent, comprising:

a body having an elongated tubular configuration and a foreshortened configuration,

wherein a downstream end of the body expands into a downstream flange structure, and an upstream end of the body expands into a flared flange structure,

wherein the flared flange structure includes a ramped portion and a cylindrical portion,

wherein a cylindrical saddle region extends between the downstream flange structure and the flared flange structure, and

wherein the ramped portion of the flared flange structure includes an axial length at least as long as a maximum diameter of the cylindrical saddle region when the body is in the foreshortened configuration.

2. The stent of claim 1 , wherein the cylindrical portion of the flared flange structure is substantially parallel to the cylindrical saddle region.

3. The stent of claim 1 , wherein the flared flange structure comprises a larger maximum lateral diameter than that of the downstream flange structure when the body is in the foreshortened configuration.

4. The stent of claim 1 , wherein the flared flange structure comprises a larger maximum axial width than that of the downstream flange structure when the body is in the foreshortened configuration.

5. The stent of claim 1 , wherein the flared flange structure comprises both a larger maximum lateral diameter and a larger maximum axial width than those of the downstream flange structure when the body is in the foreshortened configuration.

6. The stent of claim 1 , where at least a portion the flared flange structure is uncovered and the downstream flange structure is covered.

7. A stent comprising;

a body having an elongated tubular configuration and a foreshortened configuration,

wherein a downstream end of the body expands into a double-wall flange structure, and an upstream end of the body expands into a flared flange structure,

wherein the flared flange structure includes a ramped portion and a cylindrical portion, and

wherein an axial width of the cylindrical portion is greater than an axial width of the double-wall flange structure.

8. The stent of claim 7 , further comprising a cylindrical saddle region extending between the double-wall flange structure and the flared flange structure, and wherein the cylindrical portion of the flared flange structure is substantially parallel to the cylindrical saddle region.

9. The stent of claim 7 , wherein an axial width of a distal portion of the ramped portion is greater than an axial width of the double-wall flange structure.

10. The stent of claim 8 , wherein the double-wall flange structure, the cylindrical saddle region and the cylindrical portion of the flared flange structure comprises a covered mesh, and the ramped portion of the flared flange structure comprises an uncovered mesh.

11. A method, comprising:

advancing a stent into a first body lumen, wherein the stent includes an elongated tubular configuration and a foreshortened configuration, wherein a downstream end of the body expands into a downstream flange structure, and an upstream end of the body expands into a flared flange structure, wherein the flared flange structure includes a ramped portion and a cylindrical portion;

advancing the stent into a second body lumen through an opening in the first body lumen;

expanding the upstream end of the body into the flared flange structure within the second body lumen; and

expanding the downstream end of the body into the downstream flange structure within the first body lumen.

12. The method of claim 11 , wherein at least the cylindrical portion of the flared flange structure contacts a wall of the second body lumen.

13. The method of claim 11 , wherein a surface of the downstream flange structure contacts a wall of the second body lumen.

14. The method of claim 11 , wherein the downstream flange structure is configured with a double-wall.

15. The method of claim 11 , wherein the first body lumen is a duodenum and the second body lumen is a common bile duct.

16. A stent, comprising:

a body having an elongated tubular configuration and a foreshortened configuration,

wherein a downstream end of the body expands into a double-wall flange structure, an upstream end of the body expands into a flared flange structure, and a cylindrical saddle region extends between the double-wall flange structure and the flared flange structure,

wherein the flared flange structure includes a ramped portion and a cylindrical portion, and

wherein an axial width of a distal portion of the ramped portion is greater than an axial width of the double-wall flange structure.

17. The stent of claim 16 , wherein the ramped portion of the flared flange structure includes an axial length at least as long as a maximum diameter of the cylindrical saddle region when the body is in the foreshortened configuration.

18. The stent of claim 16 , wherein the flared flange structure comprises a distal-most opening having a diameter larger than a maximum internal diameter of the cylindrical saddle region when the body is in the foreshortened configuration.

19. The stent of claim 16 , wherein the double-wall flange structure, the cylindrical saddle region and the cylindrical portion of the flared flange structure comprises a covered mesh, and the ramped portion of the flared flange structure comprises an uncovered mesh.

20. The stent of claim 16 , wherein an axial width of the cylindrical portion is greater than an axial width of the double-wall flange structure.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2020
From: XLUMENA, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 053137/0170 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2020
From: BINMOELLER, KENNETH F.; DUONG, SIEU T.; DUONG, HANH H.; NGUYEN, THAO
To: XLUMENA, INC.
Reel/Frame 051764/0319 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2018
From: BINMOELLER, KENNETH; DUONG, SIEU T.; DUONG, HANH; NGUYEN, THAO
To: XLUMENA, INC.
Reel/Frame 046100/0001 →
Continuity (3)
Continuation 14743191 · Jun 18, 2015
Provisional Application 62013908 · Jun 18, 2014
Related Publication 20180289463A1 · Oct 11, 2018
Cited By (2)
US 12,310,832 US 12,521,225